Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$664.4M
+2.6% from 2023
Prescriptions
1.8M
$373.87 per claim
Patients
423K
178,229 prescribers
Total spending, 2024
$664.6M
$1,572.18 per patient
Medicare prescription drug plans paid $664.4M for Basaglar Kwikpen U-100 in 2024, for 1,777,068 prescriptions and refills to 422,574 patients (up 2.6% from 2023). The average cost per claim was $373.87.
California had the highest Medicare cost for Basaglar Kwikpen U-100 in 2024: $72.2M for 213,867 claims, followed by New York ($69.2M).
Scott A Brock, endocrinology in Dubuque, IA, had the highest Medicare cost for Basaglar Kwikpen U-100 in 2024: 426 claims costing $286K.
Basaglar Kwikpen U-100 is made by Eli Lilly and Company (LLY), listed in the Medicare spending data as Eli Lilly & Co..
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Scott A Brock Dubuque, IA | Endocrinology | 426 | 102 | $286K |
| Stella Ilyayeva Rego Park, NY | Internal Medicine | 861 | 211 | $265K |
| Dennis Roy M Ferrer |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 168,256 | 1,701,395 | 379,498 | $706.4M |
| 2023 | 159,336 | 1,537,358 | 351,852 | $647.3M |
| 2024 | 178,229 | 1,777,068 | 422,574 | $664.4M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Endocrinology |
| 304 |
| 90 |
| $245K |
| Vishal Bhatia Evansville, IN | Endocrinology | 342 | 125 | $236K |
| Tri R Lee Houston, TX | Endocrinology | 359 | 90 | $233K |
| Fauzia F Syed-Khan Astoria, NY | Internal Medicine | 480 | 110 | $224K |
| Mohammed M Rahman Elmhurst, NY | Internal Medicine | 365 | 78 | $223K |
| Mohamad K Alnabelsi Rancho Mirage, CA | Endocrinology | 294 | 75 | $218K |
| Tom M Thomas Webster, TX | Endocrinology | 342 | 103 | $200K |
| Howard A Fogel Stoughton, MA | Endocrinology | 280 | 73 | $194K |
| Leon Kujmanian Glendale, CA | Endocrinology | 578 | 120 | $180K |
| Jane M Bridges Vincennes, IN | Family Practice | 238 | 61 | $176K |
| Zarmen Israelian Glendale, CA | Endocrinology | 525 | 112 | $175K |
| Jeffrey L Rochen Houston, TX | Endocrinology | 329 | 93 | $160K |
| Lucy M Ortega Medford, OR | Physician Assistant | 217 | 64 | $143K |
| Amy McDermott Dubuque, IA | Nurse Practitioner | 249 | 75 | $137K |
| Shant A Parseghian Stoneham, MA | Endocrinology | 166 | 64 | $135K |
| Christine V Hoogasian Worcester, MA | Nurse Practitioner | 268 | 74 | $130K |
| Michael W Lin San Gabriel, CA | Endocrinology | 354 | 73 | $129K |
| Mahmood F Moosa Monroe, MI | Endocrinology | 192 | 60 | $129K |
| Paul M Tejera Canton, NY | Endocrinology | 210 | 45 | $125K |
| Craig G Haber Timonium, MD | Endocrinology | 115 | 30 | $125K |
| Shmaila Ishaq Fort Lauderdale, FL | Endocrinology | 220 | 66 | $124K |
| Khoren Hekimian Troup, TX | Family Practice | 525 | 96 | $124K |
| Ziad G Farah Harwich, MA | Endocrinology | 173 | 58 | $124K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Eli Lilly & Co. LLY | 1,777,659 | $664.6M |